We have evaluated the laboratory performance and clinical usefulness of the Roche fructosamine kit. As used with an Abbott ABA 100 bichromatic analyzer, the kit response varied linearlywith fructosamine concentration to 5.0 mmolfL (deoxymorpholinofructose equivalents). Interbatch precision was 4.1% and 3.6% for respective fructosamine concentrations of 3.2 and 5.0 mmol/L; intrabatch precision was 3.2% and 3.0% (fructosamine = 3.0 and 4.0 mmol/L).
In 55 nondiabetic subjects all fructosamine values were <3.0 mmol/L, 95% were <2.7 mmol/L.
For both fructosamine and glycated hemoglobin (Hb A10) the 95th percentile of the reference range corresponded to approximately the 10th percentile of values observed in 108 diabetic subjects. In the latter subjects fructosamine concentrations correlated somewhat (r = 0.6504) with the Hb A10 value and for eight diabetic subjects indicated a similar degree of diabetic control over a 10-week period. 
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mmoliL).
Similarly, the intrabatch precision was 3.2% (n = 10, fructosamine 
Storage:
The fructosa.mine concentration in a serum stored for 15 days at 6 #{176}C was 3.3 and 3.4 mmol!L on days 1 and 15, respectively. Here we have assessed a commercially available kit for the measurement of fructosamine. 
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